IndiaTickerBacil Pharma Ltd - 524516 - Announcement Under Regulation 30, LODRBSE · exchange filing · pdf
Source filing Company dossier
Bacil Pharma
BSE:BACPHAR · ISIN INE711D01018
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Bacil Pharma
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Bacil Pharma Ltd - 524516 - Attached Resignation Of Directors As Query Raised From BSEBSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of The SEBI (Listing Obligations And
Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Announcement under Regulation 30 (LODR)-Raising of FundsBSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Intimation Regarding Approval Of Name For Proposed Wholly-Owned SubsidiaryBSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Board Meeting Intimation for We Hereby Inform You That A Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Thursday, 9Th July 2026BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Intimation For Appointment Of Independent DirectorBSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Withdrawal Of Intimation For Appointment Of Independent DirectorsBSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On 26Th June, 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Intimation Of Proposed Incorporation Of Wholly-Owned SubsidiaryBSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Bacil Pharma Ltd - 524516 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Company Has Not Entered Any Related Party Transactions During The Half Year Ended 31St March, 2026.BSE · related party · pdf
Source filing Bacil Pharma Ltd - 524516 - Statement Of Deviation Or Variation In Utilization Of Funds Under Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Is Not Applicable To The Company For The Quarter Ended 31St March, 2026.BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Board Meeting Outcome for Outcome Of Board Meeting For Audited Results For 31St March, 2026BSE · financial results · pdf
Source filing Bacil Pharma Ltd - 524516 - Audited Financial Results For 31St March, 2026BSE · financial results · pdf
Source filing Bacil Pharma Ltd - 524516 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 22Nd May 2026BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Clarification On Price MovementBSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th February, 2026BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Unaudited Financial Result For 31St December, 2025BSE · financial results · pdf
Source filing Bacil Pharma Ltd - 524516 - Revised Un-Audited Financial Result For 31St December, 2025BSE · financial results · pdf
Source filing Bacil Pharma Ltd - 524516 - Board Meeting Intimation for We Wish To Inform You That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Friday, 13Th February, 2026BSE · exchange filing · pdf
Source filing Bacil Pharma Ltd - 524516 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing